Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

COVID-19 resources meant to streamline pandemic efforts
October 2020
SHARING OPTIONS:

WALTHAM, Mass.—PerkinElmer Inc. recently launched two free-access Perkin Elmer COVID-19 Data Dashboards—the PerkinElmer COVID-19 Drug Compound Dashboard and the PerkinElmer COVID-19 Clinical Trial Dashboard—as online resources for the scientific community as efforts continue to find antivirals and vaccines for the virus. The dashboards are supported by the company's Signals Lead Discovery and the TIBCO Spotfire advanced analytics platform, which offers a robust option for searching and aggregating drug candidate and clinical trial data. The first dashboard enables users to search through 1.6 million drug compounds and interrogate the CAS COVID-19 Antiviral Candidate Compound Dataset, a curated chemical substance dataset provided by CAS, a division of the American Chemical Society. The second dashboard pulls trial data from sources such as clinicaltrials.gov on trial status, compounds of study and other relevant information.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.